不同病种IMRT计划验证通过率差异分析

doi:10.3760/cma.j.issn.1004-4221.2017.01.011

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (837 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

目的研究不同病种IMRT计划通过率之间差异性及在确定通过率阀值的应用。方法连续选取已验证过的食管癌、鼻咽癌、乳腺癌、宫颈癌、肺癌IMRT计划各35例,使用一维方差分析方法检验通过率差异性。分析采用单一通过率阀值检验各种IMRT计划,并依据正态分布规律计算不同肿瘤IMRT计划验证通过率阈值。结果 5组数据的组间平均值差异有统计学意义(F=35.83,P<0.01),其中鼻咽癌组与其他四组之间统计结果均为P=0.000;乳腺癌组与食管癌组、肺癌组之间统计结果分别为P=0.001、P=0.033。使用单一阀值检验所有计划是不合适的,应使用各自阀值,各组阀值计算结果分别为93.37%、89.34%、97.68%、95.99%、95.42%。结论不同病种计划应使用不同阀值,正态分布规律可以计算各自阀值。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王勇
	李俊萍
	张玲玲
	王开铭
	蔡文杰

关键词 ：调强放疗计划, 剂量验证, 质量控制

Abstract：

Objective To investigate the difference in the pass rate of intensity-modulated radiation therapy (IMRT) planning in patients with different tumors and its value in determining pass rate thresholds. Methods A total of 35 verified IMRT plans for each of esophageal cancer, nasopharyngeal carcinoma, breast cancer, cervical cancer, and lung cancer were selected consecutively, and a one-way analysis of variance was used to investigate the difference in pass rate. A single pass rate threshold was used to test all IMRT plans, and the pass rate thresholds of IMRT plans for different tumors were calculated based on normal distribution law. Results There was a significant difference in the means between the 5 groups of data (F=35.83, P<0.01), and there was also a significant difference between any two groups (P=0.000).There were statistically significant differences between nasopharyngeal carcinoma group and other four groups (P=0.000). The difference was not only significant between the breast cancer group and the esophageal cancer group (P=0.001), but also between the breast cancer group and the lung cancer group (P=0.033). The calculated results of each threshold were 93.37%, 89.34%, 97.68%, 95.99%, and 95.42%, respectively. Conclusions Different thresholds should be used for IMRT plans for different tumors, and the normal distribution law can be used to calculate the threshold.

Key words： Intensity modulated radiation therapy planning Dose verification Quality control

收稿日期: 2016-06-20

引用本文:

王勇,李俊萍,张玲玲等. 不同病种IMRT计划验证通过率差异分析[J]. 中华放射肿瘤学杂志, 2017, 26(1): 50-52.

Wang Yong,Li Junping,Zhang Lingling et al. The differences among the pass rate of intensity modulated radiation therapy planning in different tumors[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 50-52.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2017.01.011 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2017/V26/I1/50

[1] Nelms BE,Simon JA.A survey on planar IMRT QA analysis[J].J Appl Clin Med Phys,2007,17(3):76-90.
[2] Jursinic PA,Nelms BE.A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery[J].Med Phys,2003,30(5):870-879.
[3] Low DA,Dempsey JF.Evaluation of the gammax dose distribution comparison method[J].Med Phys,2003,30(9):2455-2464.
[4] Li JG,Yan G,Liu C.Comparison of two commercial detector arrays for IMRT quality assurance[J].J Appl Clin Med Phys,2009,10(2):62-74.
[5] 李智华,蒋胜鹏.调强放疗剂量验证影响因素探讨[J].中华放射肿瘤学杂志,2010,19(6):575-576.DOI:10.3760/cma.j.issn.1004-4221.2010.06.029.
Li ZH,Jiang SP.Influence factors of dose verification for intensity modulated radiation therapy[J].Chin J Radiat Oncol,2010,19(6):575-576.DOI:10.3760/cma.j.issn.1004-4221.2010.06.029.
[6] 马金利,蒋国梁,廖源.调强适形放射治疗的剂量学验证[J].中华放射肿瘤学杂志,2003,12(1):64-67.
Ma JL,Jiang GL,Liao Y.Dosimetric verification of intensity-modulated radiation therapy[J].Chin J Radiat Oncol,2003,12(1):64-67.
[7] 杨鑫,刘文长.质量控制过程中的统计技术[M].北京:化学工业出版社,2014:58-76.
Yang X,Liu WC.Statistical techniques in quality control[M].Beijing:Chemical Industry Press,2014:58-76.
[8] 郭仿平,何兰.概率论与数理统计[M].北京:机械工业出版社,2005:101-111.
Guo FP,He L.Probability theory and mathematical statistics[M].Beijing:Machinery Industry Press,2005:101-111.
[9] 李成强,李光俊,冀传仙,等.ArcCHECK半导体探头特性及在容积调强弧形治疗剂量验证应用研究[J].中华放射肿瘤学杂志,2013,22(3):253-257.DOI:10.3760/cma.j.issn.1004-4221.2013.03.024.
Li CQ,Li GJ,Ji CX,et al. The characteristics and clinical application of the ArcCHECK diode array for volumetric-modulated arc therapy verification[J].Chin J Radiat Oncol,2013,22(3):253-257.DOI:10.3760/cma.j.issn.1004-4221.2013.03.024.